Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Post-Transplantation Cyclophosphamide and Abatacept Graft-Versus-Host-Disease Prophylaxis Shows Improved Outcomes in North American Adult T-Cell Leukemia/Lymphoma

Blood (2024) 144 (Supplement 1): 7367.

https://doi.org/10.1182/blood-2024-207521

Published: 2024

Journal Articles

Pre-Conditioning Easix Is Associated with Survival after Autologous Hematopoietic Stem Cell Transplant in Mature T-Cell Lymphomas

Blood (2022) 140 (Supplement 1): 12928–12929.

https://doi.org/10.1182/blood-2022-170810

Published: 2022

Journal Articles

A Single Center Analysis of Hematopoietic Recovery in Patients Undergoing Allogeneic BMT with Suboptimal CD34+ Doses

John X Wei, Nina Samuel, Richard Elkind, Carlo Palesi, Aditi Shastri, R. Alejandro Sica, Ioannis Mantzaris, Noah Kornblum, Kira Gritsman, Amit Verma, Mendel Goldfinger, Dennis Cooper, Nishi Shah

Blood (2022) 140 (Supplement 1): 12890–12891.

https://doi.org/10.1182/blood-2022-166689

Published: 2022

Journal Articles

Outcomes of Autologous Stem Cell Transplantation for Relapsed DLBCL in Single Center Serving a Minority Population

Blood (2022) 140 (Supplement 1): 13225–13227.

https://doi.org/10.1182/blood-2022-170633

Published: 2022

Journal Articles

Trends in Collection and Utilization of Autologous Hematopoietic Stem Cells (APBHC) Intended for Transplant in Patients with Multiple Myeloma

Nina Samuel, Lauren Laufer, Rodrigo Tanaguchi, Joel Rosiene, Carlo Palesi, Richard Elkind, Ioannis Mantzaris, Aditi Shastri, Noah Kornblum, R. Alejandro Sica, Urvi A Shah, Dennis Cooper, Amit Verma, Nishi Shah

Blood (2022) 140 (Supplement 1): 7936–7938.

https://doi.org/10.1182/blood-2022-169443

Published: 2022

Journal Articles

Evaluation of CNS Involvement in Secondary AML: Incidence and Impact on Outcome

Blood (2022) 140 (Supplement 1): 11653–11655.

https://doi.org/10.1182/blood-2022-158112

Published: 2022

Journal Articles

Allogeneic but Not Autologous Stem Cell Transplantation Improves Outcome in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma

Blood (2022) 140 (Supplement 1): 662–664.

https://doi.org/10.1182/blood-2022-170332

Published: 2022

Journal Articles

Safety of Autologous Hematopoietic Stem Cell Transplantation in Patients over 75 Years Old. Single Center Experience Serving a Minority Population

Blood (2021) 138 (Supplement 1): 1833.

https://doi.org/10.1182/blood-2021-146532

Published: 2021

Journal Articles

Cardiovascular Side Effects of Chimeric Antigen Receptor (CAR) T-Cell Products: A Single Center Experience in a Minority Rich, Ethnically Diverse Real-World Cohort

Blood (2021) 138 (Supplement 1): 3840.

https://doi.org/10.1182/blood-2021-154004

Published: 2021

Journal Articles

Neurotoxicity of Axicabtagene Ciloleucel and Long-Term Outcomes - in a Minority Rich, Ethnically Diverse Real World Cohort

Blood (2021) 138 (Supplement 1): 4842.

https://doi.org/10.1182/blood-2021-153917

Published: 2021

Journal Articles

Allogeneic Stem Cell Transplantation in a Large Urban Cohort of North-American Adult T-Cell Leukemia/Lymphoma

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-140812

Published: 2020

Journal Articles

Dynamics of Leukocyte Subpopulations Reconstitution Predict Infection Propensity in a Multiethnic Real World Cohort Treated with Anti-CD19 CAR-T Cell Therapy (Axicabtagene-Ciloleucel)

Astha Thakkar, MBBS, Zhu Cui, MD, Stephen Zachary Peeke, MD, Nishi Shah, MBBS, MPH, Amanda Lombardo, PA-C, BS, MS, Fariha Khatun, PA-C, Jennat Mustafa, PA-C, Alyssa De Castro, PharmD, Kailyn Gillick, PA-C, Felisha Joseph, PA-C, Anjali Naik, PA-C, Shafia Rahman, MD, Angelica D'Aiello, Richard Elkind, PA-C, MS, Susan Sakalian, Karen Fehn, RN, BSN, Karen Wright, RN-BC, MS, OCN, BMTCN, Michelly Abreu, ANP,MSN, Latoya Townsend Nugent, NP, Nicole Chambers, ANP/FNP, Rosmi Mathew, FNP-BC, Donika Binakaj, BBA, Randin Nelson, MD, Carlo Palesi, Monika Paroder, MD, Joan Uehlinger, MD, Yanhua Wang, MD PhD, Yang Shi, MD PhD, Xingxing Zang, PhD, Hao Wang, MS, Christopher Nishimura, BS, Xiaoxin Ren, Ulrich G. Steidl, MDPhD, Kira Gritsman, MDPhD, Murali Janakiram, Noah Kornblum, MD, Olga Derman, MD, Ioannis Mantzaris, MD MS, Aditi Shastri, MD, Rachel Bartash, MD, Yoram Puius, MD PhD, Margaret McCort, MD, Mendel Goldfinger, MD, Lizamarie Bachier-Rodriguez, MD, Amit Verma, MBBS, Ira Braunschweig, MD, R. Alejandro Sica, MD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-139533

Published: 2020

Journal Articles

Utilization & Barriers to Curative Therapies Among Adult Aplastic Anemia Patients in a Multiethnic Urban Underserved Cohort

Rose Snyder, MD, Christopher Leyton, MD, Richard Elkind, PA-C, MS, Sireesha Vutukuri, MD, Rosmi Mathew, FNP-BC, Ioannis Mantzaris, MD MS, Mendel Goldfinger, MD, Noah Kornblum, MD, Kira Gritsman, MDPhD, Amit Verma, MBBS, Lizamarie Bachier Rodriguez, MD, R. Alejandro Sica, MD, Ira Braunschweig, MD, Aditi Shastri, MD

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-142704

Published: 2020

Journal Articles

PK-Directed Intravenous Busulfan In Combination With High-Dose Melphalan and Bortezomib As Conditioning Regimen For Patients With Multiple Myeloma

Stefan K Barta, MD, MS, MRCP, Amitabha Mazumder, M.D., Jason Carter, MPH, PA-C, Lawrence Almanzar, MPH, Richard Elkind, Ramakrishna Battini, MD, Olga Derman, MD, Noah Kornblum, MD, Xiaonan Xue, Ph.D., Amit Verma, Ira Braunschweig, MD

Blood (2013) 122 (21): 5513.

https://doi.org/10.1182/blood.V122.21.5513.5513

Published: 2013

NARROW

Post-Transplantation Cyclophosphamide and Abatacept Graft-Versus-Host-Disease Prophylaxis Shows Improved Outcomes in North American Adult T-Cell Leukemia/Lymphoma

Pre-Conditioning Easix Is Associated with Survival after Autologous Hematopoietic Stem Cell Transplant in Mature T-Cell Lymphomas

A Single Center Analysis of Hematopoietic Recovery in Patients Undergoing Allogeneic BMT with Suboptimal CD34+ Doses

Outcomes of Autologous Stem Cell Transplantation for Relapsed DLBCL in Single Center Serving a Minority Population

Trends in Collection and Utilization of Autologous Hematopoietic Stem Cells (APBHC) Intended for Transplant in Patients with Multiple Myeloma

Evaluation of CNS Involvement in Secondary AML: Incidence and Impact on Outcome

Allogeneic but Not Autologous Stem Cell Transplantation Improves Outcome in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma

Safety of Autologous Hematopoietic Stem Cell Transplantation in Patients over 75 Years Old. Single Center Experience Serving a Minority Population

Cardiovascular Side Effects of Chimeric Antigen Receptor (CAR) T-Cell Products: A Single Center Experience in a Minority Rich, Ethnically Diverse Real-World Cohort

Neurotoxicity of Axicabtagene Ciloleucel and Long-Term Outcomes - in a Minority Rich, Ethnically Diverse Real World Cohort

Allogeneic Stem Cell Transplantation in a Large Urban Cohort of North-American Adult T-Cell Leukemia/Lymphoma

Dynamics of Leukocyte Subpopulations Reconstitution Predict Infection Propensity in a Multiethnic Real World Cohort Treated with Anti-CD19 CAR-T Cell Therapy (Axicabtagene-Ciloleucel)

Utilization & Barriers to Curative Therapies Among Adult Aplastic Anemia Patients in a Multiethnic Urban Underserved Cohort

PK-Directed Intravenous Busulfan In Combination With High-Dose Melphalan and Bortezomib As Conditioning Regimen For Patients With Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only